SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
156 hedge funds and large institutions have $560M invested in SANGAMO THERAPEUTICS INC in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 53 increasing their positions, 47 reducing their positions, and 36 closing their positions.
2,968% more call options, than puts
Call options by funds: $142M | Put options by funds: $4.63M
13% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 47
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 171 → 156 (-15)
32% less capital invested
Capital invested by funds: $825M → $560M (-$265M)
42% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$23.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$11.4M |
| 3 |
CCI
Columbus Circle Investors
|
+$4.42M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4.02M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$3.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$17M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$14.9M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$7.79M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$7.63M |
| 5 |
First Eagle Investment Management
New York
|
-$7.22M |
SGMO Hedge Fund Activity: Q2 2015 in Review
156 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2015, worth a combined $560M — down 32% from $825M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of SGMO and 21 opened new positions — a net loss of 15 holders — while 47 trimmed existing stakes and 53 added.
The largest buyer was Baker Bros. Advisors, adding an estimated $23.5M. The largest seller was Janus Henderson Investors US, cutting an estimated $17M.
- 156 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2015, down from 171 in Q1 2015.
- Funds reported $560M of SANGAMO THERAPEUTICS INC stock for Q2 2015, down 32% quarter-over-quarter.
- 21 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2015 and 36 closed out, a net change of -15 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q2 2015 was Baker Bros. Advisors, an estimated $23.5M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q2 2015 was Janus Henderson Investors US, an estimated $17M sold.
Based on aggregated 13F filings for Q2 2015.